VTVT
VTVT
NASDAQ · Biotechnology

Vtv Therapeutics Inc- Cl A

Biotech Stocks Healthcare Stocks
$37.65
+1.38 (+3.80%)
As of Jun 30, 10:28 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -10.9% upside
Low Target $24.17
Average Target $33.56
High Target $46.23
Current Price $37.65
Current
$37.65
Target
$33.56
$24.17 $33.56 avg $46.23
Scenario Analysis
Bear Case
$24.17
-35.8%
Low target
Base Case
$33.56
-10.9%
Avg target
Bull Case
$46.23
+22.8%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$44.00
-14.4% from high
52-Week Low
$14.00
+168.9% from low
Target vs 52W High
$33.56
-23.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%